Results for “”

Entry Author Date Location
Analysis: With a Tight Smile, Trump Details Economic Plan in Detroit 08/08/16 Detroit Ann Arbor
Cleave Bio Gets $37M From Celgene, Others For Clinical Push 08/08/16 San Francisco
Walmart Makes It Official, Acquires Jet.com for $3 Billion 08/08/16 New York
Celgene Passes on Acetylon as Another Option-to-Buy Deal Flames Out 08/08/16 Boston
Merck Surges As Bristol’s Immunotherapy Drug Stumbles in Lung Cancer 08/05/16 Boston
Biotech Roundup: Biogen Rumors, Theranos, Electro-Drugs & More 08/05/16 National
New Schools Venture Fund Offering $7M More To Education Entrepreneurs 08/05/16 San Francisco
Zeta Interactive Acquires Acxiom Impact, Gets Bigger in Silicon Valley 08/04/16 New York
FanDuel, DraftKings Return to NY as Fantasy Sports Laws Proliferate 08/04/16 New York
Foundry Group, Autodesk Lead $35M Deal With Formlabs in 3D Printing 08/04/16 Boston
Alcohol Delivery Firm Drizly Gulps $15M to Fend Off Amazon, Startups 08/04/16 Boston
Shire Steps Back in Hemophilia Gene Therapy Race, Scraps Baxalta Drug 08/03/16 Boston
More Gene Therapy Momentum as Startup Avrobio Grabs $25M From Atlas, SV 08/02/16 Boston
Pfizer Continues Gene Therapy Push With $150M Bamboo Buyout 08/01/16 Raleigh Durham
Biogen Buys Ionis Spine Disease Drug For $75M, Eyes FDA Filing 08/01/16 Boston
Biotech Roundup: Gilead Slump, Celgene Goes Trump, Hemo Data & More 07/29/16 National
At Big Hemophilia Meeting, More Data, and Promise, For Gene Therapy 07/28/16 National
With $40M Bid, Pfizer Set to Buy, And Close, Bankrupt Bind Tx 07/27/16 Boston
Kadmon Raises $75M In IPO Despite Friendly Terms For Its Lenders 07/26/16 New York
Clinton Versus Trump: Who’s Stronger on Innovation? 07/26/16 National
Verizon Gobbles Up Yahoo, Will Group It With AOL—But What About Tumblr? 07/25/16 New York
Tobira Fails Main Goal in NASH Study, But Forges Ahead To Next Trial 07/25/16 San Francisco
New York’s B12 Continues Trend of “Human-Assisted A.I.” Startups 07/25/16 New York
Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More 07/22/16 National
Audentes Prices $75M IPO As Gene Therapy Eyes First U.S. Approval 07/20/16 San Francisco
Oncorus Bags $57M, Touts Next-Gen Take on Cancer-Fighting Viruses 07/19/16 Boston
CommonBond Gets $30M in Equity, $300M in Debt Financing, Acquires Gradible 07/19/16 New York
With Celgene Deal, Jounce Lands $261M And a “Trusting Partner” 07/19/16 Boston
Ex-Epizyme CEO’s New Startup, Fulcrum, Nabs $55M For Gene Control Drugs 07/19/16 Boston
Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News 07/15/16 National
Page 3 of 99 « previous page · next page »